⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41892 | 1.00 | — | — | |
| SCHEMBL72838 | 1.00 | — | — | |
| SCHEMBL30039818 | 1.00 | — | — | |
| SCHEMBL11306813 | 0.97 | — | — | |
| SCHEMBL4106004 | 0.97 | — | — | |
| SCHEMBL25301326 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL101772 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL104802 | 0.97 | — | — | |
| SCHEMBL4106002 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL30887880 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684220-A | Preparation method of (2R, 5R) -1,2, 5-trimethylpiperazine | 江苏宝众宝达药业股份有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119462531-A | Preparation of non-azole Process for preparing tam intermediates | 广东莱佛士制药技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118678843-A | Method for improving performance of tin-lead mixed perovskite solar cell | 上海空间电源研究所 | 2024-09-20 | — | — | CN | claimed |
| CN-118619923-A | Preparation method and application of tetrahydroisoquinoline PD-L1 inhibitor | 大连理工大学 | 2024-09-10 | — | — | CN | claimed |
| CN-118019531-A | Methods for treating neurodegenerative diseases | PTC医疗公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117736117-A | Synthesis method of sabatier starter drug intermediate | 南京欧信医药技术有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-115232130-B | APN and AKT double-target inhibitor and preparation method and application thereof | 山东大学 | 2024-01-12 | — | — | CN | claimed |
| CN-113527399-B | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-114350331-B | Strong-adsorption salt-resistant plugging agent based on nano-silica and water-based drilling fluid | 西南石油大学 | 2023-01-31 | — | — | CN | claimed |
| CN-115232130-A | APN and AKT double-target-point inhibitor and preparation method and application thereof | 山东大学 | 2022-10-25 | — | — | CN | claimed |
| EP-2731601-A2 | EOSINOPHIL PEROXIDASE COMPOSITIONS AND METHODS OF THEIR USE | Exoxemis, Inc. (US) | 2014-05-21 | — | — | EP | claimed |
| CN-103764137-A | Eosinophil peroxidase compositions and methods of their use | EXOXEMIS INC | 2014-04-30 | — | — | CN | claimed |
| WO-2013009910-A2 | EOSINOPHIL PEROXIDASE COMPOSITIONS AND METHODS OF THEIR USE | EXOXEMIS, INC. (US) | 2013-01-17 | — | — | WO | claimed |
| EP-0857790-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS | KANEKA CORP (JP) | 2005-08-17 | — | — | EP | claimed |
| US-20010031487-A1 | Process for producing optically active amino compounds | KANEKA CORPORATION | 2001-10-18 | — | — | US | claimed |
| EP-0857790-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS | KANEKA CORPORATION (JP) | 1998-08-12 | — | — | EP | claimed |
| CN-1100413-A | Urethanes and ureas that induce cytokine production | AMERICAN CYANAMID CO (US) | 1995-03-22 | — | — | CN | claimed |
| WO-1987004440-A1 | HEPTANOYL-GLU-ASP-ALA-AMINO ACID IMMUNOSTIMULANTS | PFIZER INC. (US) | 1987-07-30 | — | — | WO | claimed |
| US-RE30496-E | Tripeptide derivatives with central nervous system activity and preparation thereof | AYERST, MCKENNA & HARRISON, LTD. (CA) | 1981-01-27 | — | — | US | claimed |
| US-4018912-A | Tripeptide derivatives with central nervous system activity and preparation thereof | AYERST MCKENNA AND HARRISON LTD. (CA) | 1977-04-19 | — | — | US | claimed |